TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

SUNSHINE

Infectious DiseaseDermatologyRespiratory
Generics

SUNSHINE is a generic drug manufacturer focused on Infectious Disease, Dermatology, Respiratory. Key products include MOXIFLOXACIN HYDROCHLORIDE.

2018
Since
25
Drugs
-
Trials
390
Approved (2yr)

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 24%
3 drugs Phase 3: 1 Phase 2: 5 Phase 1: 14
Dermatology 23%
3 drugs Phase 3: 5 Phase 2: 1 Phase 1: 4
Respiratory 22%
3 drugs Phase 3: 3 Phase 2: 3 Phase 1: 5
Oncology 18%
0 drugs Phase 3: 3 Phase 2: 3 Phase 1: 17
Cardiovascular 13%
4 drugs

Pipeline Strength Pro

Loading...